Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$5.13 - $9.2 $38,787 - $69,561
-7,561 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$8.64 - $11.71 $4,596 - $6,229
-532 Reduced 6.57%
7,561 $65,000
Q4 2021

Feb 11, 2022

SELL
$10.95 - $16.07 $2,649 - $3,888
-242 Reduced 2.9%
8,093 $90,000
Q3 2021

Nov 12, 2021

SELL
$12.95 - $18.24 $1,126 - $1,586
-87 Reduced 1.03%
8,335 $108,000
Q2 2021

Aug 13, 2021

SELL
$15.83 - $17.84 $205 - $231
-13 Reduced 0.15%
8,422 $139,000
Q1 2021

May 07, 2021

BUY
$15.92 - $20.3 $350 - $446
22 Added 0.26%
8,435 $145,000
Q4 2020

Feb 12, 2021

SELL
$15.65 - $19.92 $1,893 - $2,410
-121 Reduced 1.42%
8,413 $132,000
Q3 2020

Nov 04, 2020

SELL
$13.97 - $21.16 $2,696 - $4,083
-193 Reduced 2.21%
8,534 $163,000
Q2 2020

Aug 12, 2020

BUY
$10.39 - $16.07 $9,953 - $15,395
958 Added 12.33%
8,727 $120,000
Q1 2020

May 04, 2020

SELL
$8.89 - $24.94 $36,546 - $102,528
-4,111 Reduced 34.6%
7,769 $83,000
Q4 2019

Feb 05, 2020

SELL
$8.33 - $19.95 $833 - $1,995
-100 Reduced 0.83%
11,880 $222,000
Q3 2019

Nov 08, 2019

BUY
$6.86 - $10.46 $9,309 - $14,194
1,357 Added 12.77%
11,980 $125,000
Q2 2019

Aug 13, 2019

BUY
$6.99 - $11.27 $74,254 - $119,721
10,623 New
10,623 $81,000
Q2 2018

Aug 08, 2018

SELL
$4.04 - $5.13 $49,894 - $63,355
-12,350 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$3.92 - $5.35 $2,598 - $3,547
-663 Reduced 5.09%
12,350 $66,000
Q4 2017

Feb 09, 2018

BUY
$3.9 - $4.66 $237 - $284
61 Added 0.47%
13,013 $51,000
Q3 2017

Nov 09, 2017

BUY
$4.14 - $5.12 $53,621 - $66,314
12,952
12,952 $57,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $139M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.